Hemorrodil
NDC Package 61357-135-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Hemorrodil is a medication used as Active IngredientsPurposePhenylephrine Hydrochloride 0.25%VasoconstrictorCocoa Butter 88.44%Protectant. Marketed by Zurich Medical Labs, Llc, this product is identified by NDC 61357-135 and is authorized under FDA application part346.

Identification & Billing

NDC Package Code
61357-135-01
Package Description
1 BLISTER PACK in 1 CARTON / 12 SUPPOSITORY in 1 BLISTER PACK
Product Code
61357-135
11-Digit Billing Format
61357013501
RxNorm Crosswalk
  • RxCUI: 1438497 - cocoa butter 88.4 % / phenylephrine HCl 0.25 % Rectal Suppository
  • RxCUI: 1438497 - cocoa butter 0.884 MG/MG / phenylephrine hydrochloride 0.0025 MG/MG Rectal Suppository
  • RxCUI: 1491717 - Hemorrodil 88.44 % / 0.25 % Rectal Suppository
  • RxCUI: 1491717 - cocoa butter 0.884 MG/MG / phenylephrine hydrochloride 0.0025 MG/MG Rectal Suppository [Hemorrodil]
  • RxCUI: 1491717 - Hemorrodil (cocoa butter 88.44 % / phenylephrine HCl 0.25 % ) Rectal Suppository

Clinical Specifications

Proprietary Name
Hemorrodil
Dosage Form
-
Usage Information
This product is used as Active IngredientsPurposePhenylephrine Hydrochloride 0.25%VasoconstrictorCocoa Butter 88.44%Protectant. Temporarily shrinks hemorrhoidal tissuesProvides temporary relief from the itching, burning and discomfort associated with hemorrhoidsAids in protecting irritated anorectal areas

Regulatory & Marketing

Labeler Name
Zurich Medical Labs, Llc
FDA Application #
part346
Marketing Category
OTC MONOGRAPH FINAL - A product marketed pursuant to a final Over-the-Counter (OTC) Drug Monograph.
Start Marketing Date
03-01-1964
Listing Expiration
12-31-2017
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 61357-135-01 identifies a specific commercial package of 1 blister pack in 1 carton / 12 suppository in 1 blister pack of Hemorrodil, labeled by Zurich Medical Labs, Llc. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Zurich Medical Labs, Llc on March 01, 1964. The current certification is valid through December 31, 2017.

How is this Zurich Medical Labs, Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 61357013501. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
61357-135-01
11-Digit CMS (5-4-2)
61357-0135-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.